Simpler Grants.gov #RFA-CA-27-007

Funding for NCI Community Oncology Research Program (NCORP) Community Sites

This opportunity from the National Institutes of Health (NIH), via the National Cancer Institute (NCI), seeks applications for the NCI Community Oncology Research Program (NCORP) Community Sites. - Government Buyer: - National Institutes of Health (NIH) - National Cancer Institute (NCI) - Program Details: - Supports healthcare systems, consortia, community hospitals, oncology practices, public hospitals, and health care centers - Focuses on cancer control, prevention, treatment, screening, care delivery, and quality-of-life research - Aims to enhance generalizability and dissemination of clinical trial and human subject research results in community settings - Products/Services Requested: - Participation in cancer research studies (no specific products or part numbers) - Service: Cancer Research Participation at NCORP Community Sites - Unique Requirements: - Eligible applicants include government entities, nonprofits, educational institutions, and businesses - Foreign organizations and non-domestic components are excluded - Funding: - Estimated total funding: $73,000,000 - Approximately 50 awards anticipated - Place of Performance: - National Institutes of Health (federal office)

Description

This Notice of Funding Opportunity (NOFO) is for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP), which aims to enhance the generalizability and dissemination of clinical trial and other human subject research results through accrual in community settings. NCORP engages cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery. The program supports community-based research networks that design and conduct clinical trials and other studies in cancer control, prevention, screening, and care delivery, as well as quality-of-life studies embedded within treatment trials. NCORP Community Sites include healthcare systems, consortia of healthcare systems, community hospitals, oncology practices, public hospitals, and healthcare centers that improve participant representativeness in cancer-related clinical trials.

View original listing